Elixirr International plc

LSE:ELIX Lagerbericht

Marktkapitalisierung: UK£320.1m

Elixirr International Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Elixirr International wird ein jährliches Gewinn- und Umsatzwachstum von 18.1% bzw. 11.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 13.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.8% betragen.

Wichtige Informationen

18.1%

Wachstumsrate der Gewinne

13.52%

EPS-Wachstumsrate

Professional Services Gewinnwachstum11.0%
Wachstumsrate der Einnahmen11.1%
Zukünftige Eigenkapitalrendite21.80%
Analystenabdeckung

Low

Zuletzt aktualisiert06 Aug 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrative-Update Mar 27

ELIX: Rising Dividend And 2025 Guidance Will Support Further Share Upside

Analysts have maintained their £11.40 price target for Elixirr International, noting only minor adjustments to the discount rate and future P/E assumptions that do not materially change their overall view of the shares. What's in the News Elixirr International issued earnings guidance for the year ending 31 December 2025, with revenue expected to meet or exceed market expectations of £149 million, supported by continued momentum across the Group (Key Developments).
Narrative-Update Mar 11

ELIX: Rising Dividend And 2025 Revenue Guidance Will Support Further Upside

Analysts have maintained their fair value estimate for Elixirr International at £11.40, making only small adjustments to inputs such as the discount rate and future P/E assumption, which together support this unchanged price target. What's in the News Elixirr International issued earnings guidance for the year ending 31 December 2025, stating that revenue is expected to meet or exceed market expectations of £149 million, with the company attributing this to continued momentum across the Group (Company guidance).
Narrative-Update Feb 25

ELIX: Solid Dividend And 2025 Revenue Guidance Will Support Further Upside

Analysts have maintained their fair value estimate for Elixirr International at £11.40 per share, with only very small tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E. This suggests their overall price target and investment case remain broadly unchanged.
Narrative-Update Feb 10

ELIX: Rising Dividend Payout Will Support Future Upside Potential

Analysts have nudged their fair value estimate for Elixirr International to £11.40 from £11.30, citing updated assumptions for revenue growth, profit margins, and the future P/E multiple as the drivers of this refined price target. What's in the News Elixirr International issued earnings guidance for the year ending 31 December 2025, with revenue expected to meet or exceed market expectations of £149 million, supported by what the company describes as continued momentum across the Group (Key Developments).
Narrative-Update Jan 27

ELIX: Dividend Momentum And Upbeat Guidance Will Support Future Upside Potential

Analysts have slightly reduced their price target for Elixirr International, bringing the new figure to just below the previous level. This reflects very minor adjustments to discount rate, revenue growth and profit margin assumptions, while the fair value estimate remains steady at £11.30.
Analyseartikel Jan 25

Elixirr International (LON:ELIX) Has Announced A Dividend Of £0.076

Elixirr International plc's ( LON:ELIX ) investors are due to receive a payment of £0.076 per share on 24th of...
Narrative-Update Jan 10

ELIX: Steady Assumptions Will Support Strong Future Momentum And Upside Potential

Analysts have held their fair value estimate for Elixirr International steady at £11.30 per share, indicating only marginal tweaks to the discount rate and future P/E assumptions rather than any change in their core view of the company. Valuation Changes Fair Value Estimate was held steady at £11.30 per share, with no change between the prior and updated assessment.
Narrative-Update Dec 21

ELIX: Modestly Higher Revenue Outlook Will Support Strong Future Momentum And Upside Potential

Analysts have nudged their price target for Elixirr International slightly higher to align with modestly improved revenue growth expectations and a steady fair value estimate of £11.30 per share. Valuation Changes Fair Value Estimate is unchanged at £11.30 per share, indicating no material reassessment of intrinsic value.
Narrative-Update Dec 06

ELIX: Index Inclusions Will Drive Strong Future Momentum And Upside Potential

Narrative Update on Elixirr International Analysts have nudged their price target on Elixirr International slightly higher to align more closely with its steady fair value estimate of £11.30, citing marginally lower discount rates and sustained expectations for strong revenue growth and profit margins. What's in the News Elixirr International plc has been added to the FTSE All Share Index, increasing its visibility among UK institutional investors (index announcement).
Narrative-Update Nov 22

ELIX: Index Additions Will Drive Sustained Market Momentum This Year

Narrative Update: Elixirr International Analyst Price Target Revision Analysts have maintained their price target for Elixirr International at £11.30, citing stable growth projections and consistent profit margins as key factors for this unchanged outlook. What's in the News Elixirr International plc (LSE:ELIX) has been added to the S&P Global BMI Index (Key Developments).
Narrative-Update Nov 06

ELIX: Inclusion in Major Indexes Will Support Momentum in Coming Months

Narrative Update on Elixirr International: Analyst Price Target Revision Analysts have maintained their fair value estimate for Elixirr International at £11.30 per share, citing stable outlooks across core financial metrics and no material updates from recent research. What's in the News Elixirr International plc (LSE:ELIX) has been added to the S&P Global BMI Index (Key Developments) Elixirr International plc (LSE:ELIX) has been added to the FTSE All-Share Index (GBP) (Key Developments) Valuation Changes Fair Value Estimate remains unchanged at £11.30 per share.
Narrative-Update Oct 22

Analysts Maintain Positive Outlook on Elixirr International Amid Index Additions and Stable Valuation

Analysts have maintained their price target for Elixirr International at £11.30, reflecting only minor adjustments in key assumptions. This is due to a steady financial outlook and marginal improvements in profit margin and discount rate.
Narrative-Update Oct 08

Leadership Commitment And AI Expansion Will Drive Future Success

Elixirr International’s analyst fair value price target has been raised from £10.32 to £11.30. Analysts cite improved revenue growth prospects and higher projected profit margins as the main drivers for the upgrade.
Analyseartikel Sep 29

We Like The Quality Of Elixirr International's (LON:ELIX) Earnings

Elixirr International plc's ( LON:ELIX ) solid earnings announcement recently didn't do much to the stock price. We did...
Analyseartikel Jul 14

Elixirr International (LON:ELIX) Will Pay A Larger Dividend Than Last Year At £0.115

The board of Elixirr International plc ( LON:ELIX ) has announced that it will be paying its dividend of £0.115 on the...
Analyseartikel Jun 27

Elixirr International (LON:ELIX) Will Pay A Larger Dividend Than Last Year At £0.115

Elixirr International plc ( LON:ELIX ) will increase its dividend from last year's comparable payment on the 20th of...
Analyseartikel Jun 01

Elixirr International (LON:ELIX) Is Paying Out A Larger Dividend Than Last Year

Elixirr International plc ( LON:ELIX ) has announced that it will be increasing its dividend from last year's...
Analyseartikel May 04

Optimistic Investors Push Elixirr International plc (LON:ELIX) Shares Up 31% But Growth Is Lacking

Elixirr International plc ( LON:ELIX ) shares have had a really impressive month, gaining 31% after a shaky period...
User avatar
Neues Narrative Mar 18

Leadership Commitment And AI Expansion Will Drive Future Success

Strong insider commitment and strategic acquisitions focus on AI and organizational transformation, fueling growth and earnings potential.
Analyseartikel Dec 24

Elixirr International's (LON:ELIX) Dividend Will Be £0.063

The board of Elixirr International plc ( LON:ELIX ) has announced that it will pay a dividend of £0.063 per share on...
Analyseartikel Nov 28

Elixirr International plc (LON:ELIX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

The Elixirr International plc ( LON:ELIX ) share price has done very well over the last month, posting an excellent...
Analyseartikel Jul 23

Elixirr International (LON:ELIX) Is Due To Pay A Dividend Of £0.095

The board of Elixirr International plc ( LON:ELIX ) has announced that it will pay a dividend on the 20th of August...
Analyseartikel Jun 19

Here's Why Shareholders May Want To Be Cautious With Increasing Elixirr International plc's (LON:ELIX) CEO Pay Packet

Key Insights Elixirr International will host its Annual General Meeting on 25th of June CEO Stephen Newton's total...
Analyseartikel Jun 04

Elixirr International (LON:ELIX) Will Pay A Dividend Of £0.095

Elixirr International plc ( LON:ELIX ) will pay a dividend of £0.095 on the 20th of August. However, the dividend yield...
Analyseartikel Dec 28

Are Investors Undervaluing Elixirr International plc (LON:ELIX) By 45%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Elixirr International fair value estimate is UK£10.11 Current...
Analyseartikel Nov 21

Elixirr International (LON:ELIX) Is Doing The Right Things To Multiply Its Share Price

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Analyseartikel Sep 05

Should You Be Adding Elixirr International (LON:ELIX) To Your Watchlist Today?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analyseartikel May 22

Elixirr International's (LON:ELIX) Dividend Will Be Increased To £0.108

Elixirr International plc's ( LON:ELIX ) dividend will be increasing from last year's payment of the same period to...
Analyseartikel Feb 25

Returns Are Gaining Momentum At Elixirr International (LON:ELIX)

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...

Gewinn- und Umsatzwachstumsprognosen

LSE:ELIX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20282143647605
12/31/20272003344575
12/31/20261853037505
12/31/2025150203333N/A
9/30/2025140193232N/A
6/30/2025130193031N/A
3/31/2025121173030N/A
12/31/2024111162929N/A
9/30/2024104172525N/A
6/30/202497182021N/A
3/31/202492181819N/A
12/31/202386171717N/A
9/30/202383161818N/A
6/30/202380141919N/A
3/31/202376131717N/A
12/31/202272131516N/A
9/30/202266121414N/A
6/30/202260121212N/A
3/31/202255111313N/A
12/31/202151101414N/A
9/30/20214691212N/A
6/30/202141899N/A
3/31/20213661111N/A
12/31/20203051212N/A
12/31/201926233N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ELIXDas prognostizierte Gewinnwachstum (18.1% pro Jahr) liegt über der Sparquote (3.6%).

Ertrag vs. Markt: ELIXDie Erträge des Unternehmens (18.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (11.6% pro Jahr).

Hohe Wachstumserträge: ELIXDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: ELIXDie Einnahmen des Unternehmens (11.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (4% pro Jahr).

Hohe Wachstumseinnahmen: ELIXDie Einnahmen des Unternehmens (11.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ELIXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.8%)


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/08/09 16:52
Aktienkurs zum Tagesende2026/08/07 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Elixirr International plc wird von 7 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
James FletcherBerenberg
James WoodCanaccord Genuity
Guy HewettCavendish